<DOC>
	<DOCNO>NCT00462813</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention use certain drug keep cancer forming . The use diindolylmethane , substance find cruciferous vegetable , may keep cervical intraepithelial neoplasia cervical cancer forming . PURPOSE : This randomized phase III trial study diindolylmethane see well work compare placebo treat patient abnormal cervical cell .</brief_summary>
	<brief_title>Diindolylmethane Treating Patients With Abnormal Cervical Cells</brief_title>
	<detailed_description>OBJECTIVES : - Compare effect diindolylmethane v placebo reduce prevalence histologically proven high-grade cervical intraepithelial neoplasia patient low-grade cervical cytological abnormality . - Compare effect regimens reduce prevalence cytological abnormality patient . - Compare effect regimens change clinical appearance cervix patient . - Determine diindolylmethane offer benefit relation human papillomavirus ( HPV ) status , include HPV type , viral load , integration . - Determine side effect supplementation diindolylmethane . - Determine effect drug migraine , mastalgia , weight , premenstrual syndrome ( PMS ) . OUTLINE : This double-blind , randomize , placebo-controlled , multicenter study . Patients randomize 1 2 treatment arm . - Arm I : Patients receive oral diindolylmethane daily 6 month . - Arm II : Patients receive oral placebo daily 6 month . Patients undergo cervical sample baseline 6 month Pap test liquid base cytology human papillomavirus ( HPV ) test polymerase chain reaction . Some patient also undergo urine hair sample collection baseline 3 6 month . Samples analyze estrogen diindolylmethane metabolite , monitor patient compliance response treatment . Some patient cervical photograph take use colposcope baseline 6 month . All patient undergo colposcopy 6 month . Patients complete questionnaire baseline ( i.e. , reproductive history , diet , smoking , premenstrual symptom ) 6 month ( i.e. , side effect , compliance , change smoke , contraception use ) . Patients moderate severe premenstrual syndrome ( PMS ) also complete PMS questionnaires monthly month 1-6 4 month follow completion study therapy . All patient instruct maintain current diet keep cruciferous vegetable soy product constant study course . After completion study treatment , patient follow periodically 7 year . PROJECTED ACCRUAL : A total 3,000 patient accrue study .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : First mildly dyskaryotic Pap smear second borderline Pap smear take within Cervical Screening Wales program Patients surveillance follow treatment highgrade cervical intraepithelial neoplasia eligible No clinical suspicion concurrent invasive cervical cancer PATIENT CHARACTERISTICS : No invasive cancer within past 3 year No know HIV positivity Not pregnant nursing Not plan become pregnant within next 6 month PRIOR CONCURRENT THERAPY : No concurrent immunosuppressive drug , warfarin , theophylline No concurrent proton pump inhibitor drug ulcer reflux disease ( i.e. , rabeprazole , esomeprazole magnesium , lansoprazole , omeprazole , pantoprazole sodium )</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>cervical cancer</keyword>
	<keyword>cervical intraepithelial neoplasia grade 2</keyword>
	<keyword>cervical intraepithelial neoplasia grade 3</keyword>
	<keyword>cervical intraepithelial neoplasia grade 1</keyword>
</DOC>